Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Do I need an engineer for my construction project?
What about the First Home Savings Account?
10 essential considerations when selling your business
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall